Cited 11 times in
p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.